Basics |
Atyr Pharma, Inc.
|
IPO Date: |
May 12, 2015 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$422.77M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.10 | 3.49%
|
Avg Daily Range (30 D): |
$0.16 | 4.19%
|
Avg Daily Range (90 D): |
$0.15 | 4.18%
|
Institutional Daily Volume |
Avg Daily Volume: |
.09M |
Avg Daily Volume (30 D): |
1.67M |
Avg Daily Volume (90 D): |
1.44M |
Trade Size |
Avg Trade Size (Sh.): |
168 |
Avg Trade Size (Sh.) (30 D): |
160 |
Avg Trade Size (Sh.) (90 D): |
154 |
Institutional Trades |
Total Inst.Trades: |
26 |
Avg Inst. Trade: |
$1.88M |
Avg Inst. Trade (30 D): |
$.96M |
Avg Inst. Trade (90 D): |
$1.55M |
Avg Inst. Trade Volume: |
.66M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.04M |
Avg Closing Trade (30 D): |
$1.4M |
Avg Closing Trade (90 D): |
$.93M |
Avg Closing Volume: |
270.06K |
|
|
Financials |
|
TTM |
FY 2024 |
Q3 2024 |
Basic EPS
|
$-.17
|
$-.86
|
$-.23
|
Diluted EPS
|
$-.17
|
$-.86
|
$-.23
|
Revenue
|
$ M
|
$ .24M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -14.88M
|
$ -64.02M
|
$ -17.26M
|
Operating Income / Loss
|
$ -15.77M
|
$ -67.91M
|
$ -18.14M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -1.21M
|
$ -12.02M
|
$ 4.68M
|
PE Ratio
|
|
|
|
|
|
|